source
- FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with NovoEli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a longer-acting alternative to daily basal insulin injec…Endpoints · 1mo ago↗ source
- FDA panel questions effectiveness of Grail's early-cancer detection testFDA's Molecular and Clinical Genetics Panel and agency officials raised concerns about Grail's next-generation sequencing test designed to detect multiple cancers early in adults over 50. The advi…